Influence of diabetes on homocysteine-lowering therapy in chronic hemodialysis patients

Clinica Chimica Acta

Volumn 412, Issue 13-14, 2011, Pages 1234-1239

  Lu, Kuo Cheng ^a   Ma, Wen Ya ^a   Chen, Chun Chi ^b   Hung, Kuo Chin ^a   Chen, Hsiao Shuang ^a   Wu, Chia Chao ^b   Chang, Tzu Yuan ^c  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b TRI SERVICE GENERAL HOSPITAL   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Diabetes; Folic acid; Hemodialysis; High sensitivity C reactive protein; Homocysteine; Vitamin B

Indexed keywords

C REACTIVE PROTEIN; FOLIC ACID; HOMOCYSTEINE; VITAMIN B COMPLEX;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; FEMALE; HEMODIALYSIS PATIENT; HUMAN; HYPERHOMOCYSTEINEMIA; MALE; PRIORITY JOURNAL; TREATMENT DURATION; UREMIA;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; DIABETES COMPLICATIONS; DIETARY SUPPLEMENTS; FOLIC ACID; HOMOCYSTEINE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RENAL DIALYSIS; UREMIA; VITAMIN B 12;

EID: 79955397672     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2011.03.020     Document Type: Article

References (27)

1. Chang T.Y., Chou K.J., Tseng C.F., et al. Effects of folic acid and vitamin B complex on serum C-reactive protein and albumin levels in stable hemodialysis patients. Curr Med Res Opin 2007, 23:1879-1886.
2. Oishi K., Nagake Y., Yamasaki H., et al. The significance of serum homocysteine levels in diabetic patients on haemodialysis. Nephrol Dial Transplant 2000, 15:851-855.
3. Descombes E., Boulat O., Bersier L.F., Fellay G. Difference in the homocysteine-lowering effect of folic acid in haemodialysis patients with and without occlusive vascular disease. Nephrol Dial Transplant 2001, 16:585-589.
4. Ducloux D., Klein A., Kazory A., Devillard N., Chalopin J.M. Impact of malnutrition-inflammation on the association between homocysteine and mortality. Kidney Int 2006, 69:331-335.
5. Gori A.M., Sofi F., Marcucci R., Giusti B., Gensini G.F., Abbate R. Association between homocysteine, vitamin B(6) concentrations and inflammation. Clin Chem Lab Med 2007, 45:1728-1736.
6. Suliman M., Stenvinkel P., Qureshi A.R., et al. The reverse epidemiology of plasma total homocysteine as a mortality risk factor is related to the impact of wasting and inflammation. Nephrol Dial Transplant 2007, 22:209-217.
7. Daugirdas J.T. Second generation logarithmic estimates of single-pool variable volume Kt/V: an analysis of error. J Am Soc Nephrol 1993, 4:1205-1213.
8. Daugirdas J.T., Schneditz D. Overestimation of hemodialysis dose depends on dialysis efficiency by regional blood flow but not by conventional two pool urea kinetic analysis. ASAIO J 1995, 41:M719-M724.
9. Heinz J., Kropf S., Luley C., Dierkes J. Homocysteine as a risk factor for cardiovascular disease in patients treated by dialysis: a meta-analysis. Am J Kidney Dis 2009, 54:478-489.
10. Heinz J., Kropf S., Domrose U., et al. B vitamins and the risk of total mortality and cardiovascular disease in end-stage renal disease: results of a randomized controlled trial. Circulation 2010, 121:1432-1438.
11. Jamison R.L., Hartigan P., Kaufman J.S., et al. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial. JAMA 2007, 298:1163-1170.
12. Liu Y., Coresh J., Eustace J.A., et al. Association between cholesterol level and mortality in dialysis patients: role of inflammation and malnutrition. JAMA 2004, 291:451-459.
13. Jacobs R.L., House J.D., Brosnan M.E., Brosnan J.T. Effects of streptozotocin-induced diabetes and of insulin treatment on homocysteine metabolism in the rat. Diabetes 1998, 47:1967-1970.
14. Durand P., Prost M., Loreau N., Lussier-Cacan S., Blache D. Impaired homocysteine metabolism and atherothrombotic disease. Lab Invest 2001, 81:645-672.
15. Davies L., Wilmshurst E.G., McElduff A., Gunton J., Clifton-Bligh P., Fulcher G.R. The relationship among homocysteine, creatinine clearance, and albuminuria in patients with type 2 diabetes. Diabetes Care 2001, 24:1805-1809.
16. Brattstrom L., Lindgren A., Israelsson B., Andersson A., Hultberg B. Homocysteine and cysteine: determinants of plasma levels in middle-aged and elderly subjects. J Intern Med 1994, 236:633-641.
17. Lussier-Cacan S., Xhignesse M., Piolot A., Selhub J., Davignon J., Genest J. Plasma total homocysteine in healthy subjects: sex-specific relation with biological traits. Am J Clin Nutr 1996, 64:587-593.
18. Fonseca V., Dicker-Brown A., Ranganathan S., et al. Effects of a high-fat-sucrose diet on enzymes in homocysteine metabolism in the rat. Metabolism 2000, 49:736-741.
19. Cole N.W., Weaver K.R., Walcher B.N., Adams Z.F., Miller R.R. Hyperglycemia-induced membrane lipid peroxidation and elevated homocysteine levels are poorly attenuated by exogenous folate in embryonic chick brains. Comp Biochem Physiol B Biochem Mol Biol 2008, 150:338-343.
20. Tremblay R., Bonnardeaux A., Geadah D., et al. Hyperhomocysteinemia in hemodialysis patients: effects of 12-month supplementation with hydrosoluble vitamins. Kidney Int 2000, 58:851-858.
21. Stam F., van Guldener C., Ter Wee P.M., Jakobs C., de Meer K., Stehouwer C.D. Effect of folic acid on methionine and homocysteine metabolism in end-stage renal disease. Kidney Int 2005, 67:259-264.
22. Kalousova M., Fialova L., Skrha J., et al. Oxidative stress, inflammation and autoimmune reaction in type 1 and type 2 diabetes mellitus. Prague Med Rep 2004, 105:21-28.
23. Kelly A.S., Thelen A.M., Kaiser D.R., Gonzalez-Campoy J.M., Bank A.J. Rosiglitazone improves endothelial function and inflammation but not asymmetric dimethylarginine or oxidative stress in patients with type 2 diabetes mellitus. Vasc Med 2007, 12:311-318.
24. Schnyder G., Roffi M., Flammer Y., Pin R., Hess O.M. Effect of homocysteine-lowering therapy with folic acid, vitamin B12, and vitamin B6 on clinical outcome after percutaneous coronary intervention: the Swiss Heart study: a randomized controlled trial. JAMA 2002, 288:973-979.
25. Stott D.J., MacIntosh G., Lowe G.D., et al. Randomized controlled trial of homocysteine-lowering vitamin treatment in elderly patients with vascular disease. Am J Clin Nutr 2005, 82:1320-1326.
26. Righetti M., Tommasi A., Lagona C., La Rosa L., Uccellini M., Sessa A. Effective homocysteine-lowering vitamin B treatment in peritoneal dialysis patients. Perit Dial Int 2004, 24:373-377.
27. Baragetti I., Raselli S., Stucchi A., et al. Improvement of endothelial function in uraemic patients on peritoneal dialysis: a possible role for 5-MTHF administration. Nephrol Dial Transplant 2007, 22:3292-3297.